Kodiak Sciences · 20 hours ago
Senior Scientist / Principal Scientist, Retinal Biology
Palo Alto, CA
Full-time
Onsite
Senior Level, Lead/Staff
0+ years expKodiak Sciences Inc. is a fast-growing, clinical-stage biopharmaceutical company focused on transforming ophthalmology through innovative therapeutics. They are looking for a highly motivated cell biologist to develop novel therapies for retinal diseases as part of their Discovery Medicine group.
BiotechnologyHealthcareHealth CareTherapeutics
Hiring Manager
Cindy Ressi
Responsibilities
Lead projects and execute experiments to develop therapeutics for specific areas of retinal disease
Assist other team members in experimental design, data analysis and data reporting
Work cross-functionally with antibody discovery and chemistry groups to manage workflows and prioritize activities
Deliver regular presentations to senior leadership
Qualification
Required
PhD in relevant field (cell/molecular biology, immunology, neuroscience, etc.) and 0-10 years of relevant postdoc or industry experience
Proficiency with cell-based systems and techniques relevant to retinal biology such as angiogenesis, inflammation and/or neurodegeneration
Attention to detail; must be precise and meticulous in the planning and execution of experiments
Collaborative spirit, self-motivated and able to work both independently and as part of a team with good written and verbal communication skills
Preferred
Experience establishing primary, co-culture, and/or iPSC cell-based assays and image analysis is highly desirable
Company
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
51-200 employees
H1B Sponsorship
Kodiak Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (4)
2024 (9)
2022 (2)
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$1.22BKey Investors
ArrowMark Partners,Perceptive Advisors
2025-12-16Post Ipo Equity· $184M
2020-11-17Post Ipo Equity· $645M
2019-12-02Post Ipo Equity· $317.4M
Leadership Team
Victor Perlroth
Chairman and CEO
Recent News
2025-12-22
Company data provided by crunchbase